Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ SRAX Inc. (SRAX) Stock Forecast & Price Prediction United States | NASDAQ | Technology | Software - Application
$0.00
+0.00 (0.00%)Did SRAX Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if SRAX is one of their latest high-conviction picks.
SRAX has shown a year-to-date change of -100.0% and a 1-year change of -100.0%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for SRAX. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for SRAX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 13, 2023 | B. Riley Securities | Mike Crawford | Buy | Maintains | $4.50 |
| Sep 26, 2022 | Dawson James | Buy | Maintains | $N/A | |
| Apr 19, 2021 | Dawson James | Buy | Initiates | $N/A | |
| Feb 8, 2021 | Ladenburg Thalmann | Buy | Initiates | $N/A | |
| Nov 25, 2020 | B. Riley FBR | Buy | Initiates | $N/A | |
| Jul 6, 2020 | B. Riley FBR | Buy | Initiates | $N/A | |
| Jul 6, 2020 | B. Riley Securities | Buy | Initiates | $N/A |
The following stocks are similar to SRAX based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
SRAX Inc. has a market capitalization of $32,382 with a P/E ratio of 0.0x. The company generates $18.56M in trailing twelve-month revenue with a -84.8% profit margin.
Revenue growth is -75.4% quarter-over-quarter, while maintaining an operating margin of -21.4% and return on equity of +342.1%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Provides data analytics solutions for public companies.
The company operates on a Software-as-a-Service (SaaS) model, primarily through its Sequire platform, which helps publicly traded companies analyze investor behavior and trends. By offering actionable insights, SRAX enables its clients to enhance communication and improve investor relations, generating revenue through subscription fees and additional services.
Founded in 2009 and headquartered in California, SRAX targets micro and small-cap sectors and also organizes investor conferences to foster engagement between public companies and the financial community. The company serves clients across the U.S., Canada, and internationally.
Technology
Software - Application
122
Mr. Christopher Miglino
United States
2012
CEO Brett H. Pojunis will outline key milestones and growth strategies, focusing on AI-driven distribution, revenue growth, and improved margins in an upcoming presentation to investors.
CEO's focus on AI-driven growth and revenue increases indicates strong future performance potential, which can enhance investor confidence and drive stock value.
SRAX Inc. (OTC: SRAX) has announced a definitive merger agreement with DNA Holdings Venture Inc., with DNA shareholders set to become majority owners of SRAX upon merger closure.
The merger may alter SRAX's ownership structure and market positioning, impacting its stock value and future growth prospects, which are critical for investment decisions.
Westlake Village, Dec. 18, 2023 - The company reflects on a challenging year, emphasizing resilience amid difficulties. Further details on performance may be forthcoming.
The mention of resilience suggests potential challenges faced by the company, which could impact future performance and shareholder confidence. Investors may reassess their positions.
A presentation is scheduled for Tuesday, October 3rd, at 10:30 A.M. PT / 1:30 P.M. Investors may want to tune in for potential insights.
The scheduled presentation may reveal key insights or updates on company performance, influencing stock prices and investor sentiment. Timing can affect trading decisions.
SRAX, Inc. (OTC: SRAX) has formed an Advisory Board made up of four of its largest shareholders to enhance its financial technology services via the Sequire platform.
SRAX's creation of an Advisory Board with major shareholders may enhance strategic direction and investor confidence, potentially driving stock performance and attracting new investments.
SRAX, Inc. (OTC: SRAX) will integrate GlobeNewswire to launch a self-serve press release feature on its Sequire platform, enhancing investor communications and insights.
SRAX's integration with GlobeNewswire enhances its Sequire platform, potentially increasing user engagement and revenue, which could positively influence its stock performance.
Analyst forecasts for SRAX Inc. (SRAX) are not currently available. The stock is trading at $0.00.
According to current analyst ratings, SRAX has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $0.00. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for SRAX are not currently available. The stock is trading at $0.00.
The company operates on a Software-as-a-Service (SaaS) model, primarily through its Sequire platform, which helps publicly traded companies analyze investor behavior and trends. By offering actionable insights, SRAX enables its clients to enhance communication and improve investor relations, generating revenue through subscription fees and additional services.
Price targets from Wall Street analysts for SRAX are not currently available. The stock is trading at $0.00.
Price targets from Wall Street analysts for SRAX are not currently available. The stock is trading at $0.00.
The overall analyst consensus for SRAX is bullish. Out of 2 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell.
Stock price projections, including those for SRAX Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.